Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

Overview of attention for article published in Journal of Nephrology, August 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 37 publications that cite this research output.

37

The most recent citing publications are shown below. View all 37 publications that cite this research output on Dimensions.

New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease.

Article in Current Opinion in Nephrology & Hypertension (April 2024)

SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis

Article in Journal of Nephrology (March 2024)

Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification

Article in Frontiers in Pharmacology (February 2024)